TruDiagnostic Introduces Revolutionary Epigenetic Biomarker Proxies: New Diagnostic Approach Outperforms Traditional Lab Results

LEXINGTON, Ky., Dec. 17, 2024 /PRNewswire/ — TruDiagnostic, a global leader in advanced epigenetic research, proudly announces a groundbreaking advancement in precision medicine: the development of Epigenetic Biomarker Proxies (EBPs). This transformative way of measuring biological…